ADVANCED OR METASTATIC SOLID TUMORS
Clinical trials for ADVANCED OR METASTATIC SOLID TUMORS explained in plain language.
Never miss a new study
Get alerted when new ADVANCED OR METASTATIC SOLID TUMORS trials appear
Sign up with your email to follow new studies for ADVANCED OR METASTATIC SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo tested for tough-to-treat cancers
Disease control OngoingThis early-phase study tests an experimental drug called ERAS-601, alone or with other cancer treatments, in adults with advanced solid tumors that have not responded to standard therapies. The main goals are to check safety, find the best dose, and see if the drug can shrink tum…
Matched conditions: ADVANCED OR METASTATIC SOLID TUMORS
Phase: PHASE1 • Sponsor: Erasca, Inc. • Aim: Disease control
Last updated May 16, 2026 23:49 UTC
-
New drug WTX-330 aims to boost immune system against tough cancers
Disease control OngoingThis study tests an experimental drug called WTX-330 in about 100 adults with advanced solid tumors or non-Hodgkin lymphoma that have not responded to standard treatments. The main goals are to find safe dose levels and see if the drug can shrink tumors. Researchers will also mea…
Matched conditions: ADVANCED OR METASTATIC SOLID TUMORS
Phase: PHASE1, PHASE2 • Sponsor: Werewolf Therapeutics, Inc. • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
New drug duo targets hard-to-treat cancers with RAS mutation
Disease control OngoingThis early-stage study tests two drugs, naporafenib and trametinib, in people with advanced solid tumors that have a specific RAS Q61X gene mutation. The goal is to see if the combination can shrink tumors or slow their growth. About 86 participants aged 12 and older who have tri…
Matched conditions: ADVANCED OR METASTATIC SOLID TUMORS
Phase: PHASE1 • Sponsor: Erasca, Inc. • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
Needle-Free cancer drug? study tests Under-the-Skin shot for advanced tumors
Disease control OngoingThis early-stage study is testing a new under-the-skin injection of the cancer drug pembrolizumab in 72 adults with advanced solid tumors. The goal is to see how well the body absorbs the drug and to check for side effects. Participants receive one of two different doses. This is…
Matched conditions: ADVANCED OR METASTATIC SOLID TUMORS
Phase: PHASE1 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 11, 2026 20:49 UTC
-
New cancer drug combo tested in first human trial
Disease control OngoingThis early-stage trial tests a new drug called KGX101, alone or with another drug envafolimab, in 54 people with advanced solid tumors that have not responded to standard treatments. The main goal is to check safety and find the best dose. This is a first-in-human study, so it fo…
Matched conditions: ADVANCED OR METASTATIC SOLID TUMORS
Phase: PHASE1 • Sponsor: Kangabio AUSTRALIA LTD PTY • Aim: Disease control
Last updated May 11, 2026 20:37 UTC